ICT And Dose Intensification Of The Radiation Boost In Locally Advanced Anal Canal Carcinoma
Main Category: Radiology / Nuclear MedicineAlso Included In: Colorectal Cancer; Cancer / Oncology; GastroIntestinal / Gastroenterology
Article Date: 22 Sep 2008 - 3:00 PDT
Anal cancer is rare but the incidence is increasing, associated with HPV infection. Cure is possible in the majority of patients with the preservation of the anus and a functional anal sphincter. Abdominoperineal resection is reserved for patients with local relapse or late complications.
For locally advanced disease, a concomitant chemotherapy improved the functional results and the rate of colostomy-free survival as well as local control, but failure was observed in 25% of the patients.
A dose intensification of the treatment was studied in this prospective phase IIItrial with 307 patients included. The aim of the study was to assess the benefit on the colostomy - free survival of two cycles of induction chemotherapy (5 FU + CDDP) and an increase of the dose of irradiation delivered to the primary, from 60 to 65-70 Gy.
The tolerance was good. The results, after a mean follow-up of 3 years, showed an 88% local control rate but did not show any benefit of the intensification group compared to standard treatment in a 2X2 factorial analysis.
Further analysis will be conducted to identify a subgroup of patients who potentially benefit of intensification.
Peiffert Didier et al. Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France
About ESTRO 27
ESTRO 27 (September 14th to 18th, 2008) offered an outstanding scientific programme combining lectures from eminent invited speakers, proffered papers and poster discussions, teaching lectures on a wide range of topics including clinical issues, brachytherapy, radiobiology, physics and technology as well as debates on controversial topics and clinical case discussions, a special poster reception, poster discussion sessions and electronic poster viewing.
ESTRO 27 hosted the largest European exhibition in Radiotherapy with participation from all the leading manufacturers.
ESTRO 27
ESTRO (European Society for Therapeutic Radiology and Oncology)
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add to:
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |




